查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954662

胜肽合成市场规模、占有率、成长及全球产业分析：依产品、方法、应用、最终用户和地区划分的洞察与预测（2026-2034）

Peptide Synthesis Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 220 Pages | 商品交期: 请询问到货日

价格

胜肽合成市场成长驱动因子

2025年全球胜肽合成市场规模达7.467亿美元，预计2026年将成长至8.016亿美元。预计2034年将达到16.4052亿美元，预测期内年复合成长率高达9.39%。

北美在全球胜肽合成市场中占据领先地位，2025年市场占有率为48.59%。成长驱动因素包括对肽类药物需求的不断成长、合成技术的进步以及研发投入的增加。

胜肽合成是指利用化学或生物方法建构短胺基酸链的过程。特定序列。固相肽合成（SPPS）和液相肽合成（LPPS）等现代技术能够实现客製化胜肽的生产，用于治疗、诊断和研究应用。

市场动态

市场驱动因素

对胜肽类药物的需求不断增加

胜肽类药物因其高特异性、低毒性和优于小分子药物的安全性，其应用日益广泛，这是推动市场成长的关键因素之一。肽类药物广泛应用于肿瘤学、代谢性疾病、糖尿病和罕见疾病等领域。

例如，2025年 8月，BioMed X 与Novo Nordisk合作开发胜肽类药物的口服製剂，包括 GLP-1 受体促效剂。临床试验中胜肽类治疗药物的不断增加，显着推动了合成需求。

市场限制因子

大规模生产的技术限制因子

儘管胜肽合成市场成长强劲，但大规模胜肽合成仍面临诸多挑战，例如偶联不完全、聚集、外消旋化以及溶剂消耗量高。将固相胜肽合成（SPPS）从实验室规模扩大到商业化生产通常会导致纯化成本增加和产率降低，阻碍市场扩张。

市场机会

合成方法的技术进步

微波辅助固相胜肽合成（SPPS）、混合固相胜肽合成-液相胜肽合成（SPPS-LPPS）技术、连续流合成等创新技术改变胜肽的生产效率。这些进步降低了溶剂用量，缩短了反应週期，并提高了产率和纯度。

例如，2022年4月，CEM推出了 "Liberty Blue 2.0" 微波胜肽合成仪，溶剂用量减少了90%以上，实现了更环保的生产流程。

市场挑战

生产和纯化成本高

长链且结构复杂的胜肽需要多步骤合成，并透过高效液相层析（HPLC）进行纯化，这显着增加了成本。例如，由39个胺基酸组成的胜肽类药物替泽帕肽（Mounjaro）需要大量的纯化和复杂的生产过程，导致生产成本上升。

市场趋势

扩大外包给CDMO

一个主要的市场趋势是，越来越多的胜肽类生产外包给专业的合约研发生产力机构（CDMO）。製药公司日益选择外包，以减少基础设施投资并加快产品上市速度。

2024年7月，Corden Pharma宣布投资9亿欧元（10.472亿美元）扩大其全球胜肽类产能，凸显了外包需求的成长。

细分市场分析

依产品和服务划分

市场分为产品和服务两部分。

预计到2026年，服务部分将占据市场主导地位，市场占有率达到71.03%，这主要得益于外包业务的成长以及对大规模肽类生产需求的增加。2025年10月，Cambrex宣布投资1.2亿美元扩大其在美国的胜肽生产产能。

依方法划分

该市场包含以下方法：

  • 固相胜肽合成（SPPS）
  • 液相胜肽合成（LPPS）
  • 其他

预计到2026年，SPPS 方法将占据 74.42%的市场占有率，这主要得益于其自动化相容性、可扩展性和高效率。预计在预测期内，LPPS细分市场将以6.45%的年复合成长率成长。

依应用领域划分

主要应用领域如下：

  • 治疗药物
  • 诊断
  • 研发

预计到2026年，治疗药物细分市场将占据最大的市场占有率，达到66.25%，这主要得益于胜肽类药物商业化程度的提高和强大的临床研发管线。预计在预测期内，诊断药物细分市场将以7.35%的年复合成长率成长。

依最终使用者划分

市场区隔如下：

  • 製药和生技公司
  • CRO 和 CDMO
  • 学术和研究机构
  • 其他

在积极的治疗创新和策略合作的支持下，製药和生物技术公司预计将引领市场，在2025年占据 57.1%的市场占有率，在2026年占据 56.94%的市场占有率。 CRO 和 CDMO 细分市场预计将以 11.62%的年复合成长率成长。

区域展望

北美

北美引领市场，2025年市场规模为 3.6284亿美元，2026年为 3.8908亿美元。光是美国市场预计就将达到2026年，在强劲的生物製药研发和策略合作的推动下，市场规模将达到3.6076亿美元。

欧洲

2025年，欧洲市场规模达到1.601亿美元，年复合成长率为8.72%。法国到2025年达到2,410万美元，而英国和德国预计到2026年将分别达到3,974万美元和3,584万美元。

亚太地区

2025年，亚太地区市场规模达到1.404亿美元。到2026年，日本预计将达到4,953万美元，中国将达到3,001万美元，印度将达到2,926万美元。

拉丁美洲、中东和非洲

到2025年，拉丁美洲的市场规模达到 3,500万美元，而GCC国家到2025年的市场规模达到 1,840万美元。这些地区的成长得益于不断扩大的研发活动。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要考察

  • 胜肽合成技术发展
  • 主要国家的监管状况
  • 主要产业趋势（併购、合作等）
  • 主要公司新产品发布

第5章 全球胜肽合成市场分析、洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品分类
    • 产品
      • 设备
      • 试剂和耗材
    • 服务
      • 客製化研究级胜肽合成
      • 胜肽库合成
      • 其他
  • 市场分析、洞察与预测：依方法分类
    • 溶液相胜肽合成
    • 固相胜肽合成
    • 其他
  • 市场分析、洞察与预测：依应用分类
    • 治疗药物
    • 诊断
    • 研发
  • 市场分析、洞察与预测：依应用分类 预测：依最终用户划分
    • 製药和生技公司
    • 合约研究组织（CRO）与合约研发生产力组织（CDMO）
    • 学术和研究机构
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美胜肽合成市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第7章 欧洲胜肽合成市场分析、洞察与预测（2021-2034）

  • 依国家/地区
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 北欧国家
    • 欧洲其他地区

第8章 亚太地区胜肽合成市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 东南亚
    • 亚太其他地区

第9章 拉丁美洲胜肽合成市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他地区拉丁美洲

第10章 中东与非洲胜肽合成市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • GCC国家
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 全球市场占有率分析（2025）
  • 公司简介
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • GenScript
  • Agilent Technologies Inc.
  • Bachem AG
  • Waters Corporation
  • Danaher
  • PolyPeptide Group
  • Bio-Synthesis Inc.
  • CordenPharma
Product Code: FBI114373

Growth Factors of peptide synthesis Market

The global peptide synthesis market was valued at USD 746.7 million in 2025 and is projected to grow to USD 800.16 million in 2026. The market is further expected to reach USD 1,640.52 million by 2034, registering a strong CAGR of 9.39% during the forecast period.

North America dominated the global peptide synthesis market with a 48.59% market share in 2025. Growth is driven by rising demand for peptide-based therapeutics, technological advancements in synthesis techniques, and expanding research & development investments.

Peptide synthesis involves the chemical or biological construction of short amino acid chains in a defined sequence. Modern techniques such as solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS) enable customized peptide production for therapeutic, diagnostic, and research applications.

Market Dynamics

Market Drivers

Rising Demand for Peptide-Based Drugs

One of the primary growth drivers is the increasing adoption of peptide-based drugs due to their high specificity, low toxicity, and improved safety profiles compared to small-molecule drugs. Peptides are widely used in oncology, metabolic disorders, diabetes, and rare diseases.

For instance, in August 2025, BioMed X collaborated with Novo Nordisk to develop oral formulations for peptide drugs such as GLP-1 receptor agonists. The growing pipeline of peptide therapeutics in clinical trials is significantly driving synthesis demand.

Market Restraints

Technical Limitations in Large-Scale Production

Despite strong growth, large-scale peptide synthesis faces challenges including incomplete coupling, aggregation, racemization, and high solvent consumption. Scaling SPPS from laboratory to commercial production often results in increased purification costs and reduced yields, limiting broader market expansion.

Market Opportunities

Technological Advancements in Synthesis Methods

Innovations such as microwave-assisted SPPS, hybrid SPPS-LPPS techniques, and continuous-flow synthesis are transforming peptide production efficiency. These advancements reduce solvent usage, shorten cycle times, and improve yield and purity.

For example, in April 2022, CEM Corporation launched the Liberty Blue 2.0 microwave peptide synthesizer, reducing solvent use by over 90% and enabling greener production processes.

Market Challenges

High Production and Purification Costs

Long and structurally complex peptides require multi-step synthesis and high-performance liquid chromatography (HPLC) purification, significantly increasing costs. For example, tirzepatide (Mounjaro), a 39-amino acid peptide drug, requires large-scale purification and complex production processes, contributing to higher manufacturing expenses.

Market Trends

Growing Outsourcing to CDMOs

A key trend in the market is the increasing outsourcing of peptide manufacturing to specialized Contract Development and Manufacturing Organizations (CDMOs). Pharmaceutical companies prefer outsourcing to reduce infrastructure investment and accelerate time-to-market.

In July 2024, Corden Pharma announced a €900 million (USD 1,047.2 million) investment to expand global peptide production capacity, highlighting growing outsourcing demand.

Segmentation Analysis

By Offering

The market is divided into products and services.

The services segment dominated the market with a 71.03% share in 2026, driven by increased outsourcing and rising demand for large-scale peptide manufacturing. In October 2025, Cambrex Corporation announced a USD 120 million investment to expand peptide manufacturing capacity in the U.S.

By Method

The market includes:

  • Solid-Phase Peptide Synthesis (SPPS)
  • Liquid-Phase Peptide Synthesis (LPPS)
  • Others

The SPPS segment dominated with a 74.42% share in 2026, owing to automation compatibility, scalability, and high efficiency. The LPPS segment is expected to grow at a CAGR of 6.45% during the forecast period.

By Application

Applications include:

  • Therapeutics
  • Diagnostics
  • Research & Development

The therapeutics segment held the largest share at 66.25% in 2026, driven by increasing commercialization of peptide drugs and a strong clinical pipeline. Diagnostics is projected to grow at 7.35% during the forecast period.

By End User

The market is segmented into:

  • Pharmaceutical & Biotechnology Companies
  • CROs & CDMOs
  • Academic & Research Institutes
  • Others

Pharmaceutical & biotechnology companies dominated with a 57.1% share in 2025 and 56.94% in 2026, supported by active therapeutic innovation and strategic collaborations. The CROs & CDMOs segment is projected to grow at a CAGR of 11.62%.

Regional Outlook

North America

North America led the market with a valuation of USD 362.84 million in 2025 and is projected to reach USD 389.08 million in 2026. The U.S. market alone is expected to reach USD 360.76 million by 2026, driven by strong biopharmaceutical R&D and strategic collaborations.

Europe

Europe is projected to grow at a CAGR of 8.72% and recorded USD 160.1 million in 2025. France recorded USD 24.1 million in 2025, while the UK and Germany are projected to reach USD 39.74 million and USD 35.84 million respectively by 2026.

Asia Pacific

Asia Pacific reached USD 140.4 million in 2025. By 2026, Japan is projected to reach USD 49.53 million, China USD 30.01 million, and India USD 29.26 million.

Latin America & Middle East & Africa

Latin America recorded USD 35.0 million in 2025, while GCC countries reached USD 18.4 million in 2025. Growth in these regions is supported by expanding R&D activities.

Competitive Landscape

The market is semi-consolidated with key players including:

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies Inc.
  • Bachem AG
  • PolyPeptide Group
  • Danaher

Strategic collaborations and technology upgrades strengthen competitive positioning. For instance, in May 2025, PeptiSystems partnered with Asahi Kasei Bioprocess America to enhance peptide synthesis technologies.

Conclusion

The global peptide synthesis market, valued at USD 746.7 million in 2025, is projected to grow to USD 800.16 million in 2026 and reach USD 1,640.52 million by 2034, expanding at a CAGR of 9.39%. Growth is primarily driven by rising demand for peptide-based therapeutics, technological advancements in SPPS and LPPS, and increasing outsourcing to CDMOs. Although high production costs and large-scale synthesis challenges remain, expanding R&D investments and innovative synthesis platforms are expected to sustain strong market growth through 2034.

Segmentation By Offering, Method, Application, End User, and Region

By Offering * Products

    • Instruments
      • Peptide Synthesizers
      • Lyophilizers
      • Chromatography Systems
      • Others
    • Reagents & Consumables
  • Services
    • Custom Research-Grade Peptide Synthesis
    • Peptide Library Synthesis
    • Others

By Method * Liquid-Phase Peptide Synthesis

  • Solid-Phase Peptide Synthesis
  • Others

By Application * Therapeutics

  • Diagnostics
  • Research & Development

By End User * Pharmaceutical & Biotechnology Companies

  • CROs & CDMOs
  • Academic & Research Institutes
  • Others

By Region * North America (By Offering, Method, Application, End User, and Country)

    • U.S.
    • Canada
  • Europe (By Offering, Method, Application, End User, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Offering, Method, Application, End User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Offering, Method, Application, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Offering, Method, Application, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Peptide Synthesis
  • 4.2. Regulatory Scenario, By Key Countries/Regions
  • 4.3. Key Industry Developments (Mergers, Acquisitions, and Collaborations etc.)
  • 4.4. New Product Launches, By Key Players

5. Global Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Offering
    • 5.1.1. Products
      • 5.1.1.1. Instruments
        • 5.1.1.1.1. Peptide Synthesizers
        • 5.1.1.1.2. Lyophilizers
        • 5.1.1.1.3. Chromatography Systems
        • 5.1.1.1.4. Others
      • 5.1.1.2. Reagents & Consumables
    • 5.1.2. Services
      • 5.1.2.1. Custom Research-Grade Peptide Synthesis
      • 5.1.2.2. Peptide Library Synthesis
      • 5.1.2.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Method
    • 5.2.1. Liquid-Phase Peptide Synthesis
    • 5.2.2. Solid-Phase Peptide Synthesis
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Therapeutics
    • 5.3.2. Diagnostics
    • 5.3.3. Research & Development
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Pharmaceutical & Biotechnology Companies
    • 5.4.2. CROs & CDMOs
    • 5.4.3. Academic & Research Institutes
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Offering
    • 6.1.1. Products
      • 6.1.1.1. Instruments
        • 6.1.1.1.1. Peptide Synthesizers
        • 6.1.1.1.2. Lyophilizers
        • 6.1.1.1.3. Chromatography Systems
        • 6.1.1.1.4. Others
      • 6.1.1.2. Reagents & Consumables
    • 6.1.2. Services
      • 6.1.2.1. Custom Research-Grade Peptide Synthesis
      • 6.1.2.2. Peptide Library Synthesis
      • 6.1.2.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Method
    • 6.2.1. Liquid-Phase Peptide Synthesis
    • 6.2.2. Solid-Phase Peptide Synthesis
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Therapeutics
    • 6.3.2. Diagnostics
    • 6.3.3. Research & Development
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Pharmaceutical & Biotechnology Companies
    • 6.4.2. CROs & CDMOs
    • 6.4.3. Academic & Research Institutes
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Offering
    • 7.1.1. Products
      • 7.1.1.1. Instruments
        • 7.1.1.1.1. Peptide Synthesizers
        • 7.1.1.1.2. Lyophilizers
        • 7.1.1.1.3. Chromatography Systems
        • 7.1.1.1.4. Others
      • 7.1.1.2. Reagents & Consumables
    • 7.1.2. Services
      • 7.1.2.1. Custom Research-Grade Peptide Synthesis
      • 7.1.2.2. Peptide Library Synthesis
      • 7.1.2.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Method
    • 7.2.1. Liquid-Phase Peptide Synthesis
    • 7.2.2. Solid-Phase Peptide Synthesis
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Therapeutics
    • 7.3.2. Diagnostics
    • 7.3.3. Research & Development
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Pharmaceutical & Biotechnology Companies
    • 7.4.2. CROs & CDMOs
    • 7.4.3. Academic & Research Institutes
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Offering
    • 8.1.1. Products
      • 8.1.1.1. Instruments
        • 8.1.1.1.1. Peptide Synthesizers
        • 8.1.1.1.2. Lyophilizers
        • 8.1.1.1.3. Chromatography Systems
        • 8.1.1.1.4. Others
      • 8.1.1.2. Reagents & Consumables
    • 8.1.2. Services
      • 8.1.2.1. Custom Research-Grade Peptide Synthesis
      • 8.1.2.2. Peptide Library Synthesis
      • 8.1.2.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Method
    • 8.2.1. Liquid-Phase Peptide Synthesis
    • 8.2.2. Solid-Phase Peptide Synthesis
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Therapeutics
    • 8.3.2. Diagnostics
    • 8.3.3. Research & Development
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Pharmaceutical & Biotechnology Companies
    • 8.4.2. CROs & CDMOs
    • 8.4.3. Academic & Research Institutes
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Offering
    • 9.1.1. Products
      • 9.1.1.1. Instruments
        • 9.1.1.1.1. Peptide Synthesizers
        • 9.1.1.1.2. Lyophilizers
        • 9.1.1.1.3. Chromatography Systems
        • 9.1.1.1.4. Others
      • 9.1.1.2. Reagents & Consumables
    • 9.1.2. Services
      • 9.1.2.1. Custom Research-Grade Peptide Synthesis
      • 9.1.2.2. Peptide Library Synthesis
      • 9.1.2.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Method
    • 9.2.1. Liquid-Phase Peptide Synthesis
    • 9.2.2. Solid-Phase Peptide Synthesis
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Therapeutics
    • 9.3.2. Diagnostics
    • 9.3.3. Research & Development
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Pharmaceutical & Biotechnology Companies
    • 9.4.2. CROs & CDMOs
    • 9.4.3. Academic & Research Institutes
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Offering
    • 10.1.1. Products
      • 10.1.1.1. Instruments
        • 10.1.1.1.1. Peptide Synthesizers
        • 10.1.1.1.2. Lyophilizers
        • 10.1.1.1.3. Chromatography Systems
        • 10.1.1.1.4. Others
      • 10.1.1.2. Reagents & Consumables
    • 10.1.2. Services
      • 10.1.2.1. Custom Research-Grade Peptide Synthesis
      • 10.1.2.2. Peptide Library Synthesis
      • 10.1.2.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Method
    • 10.2.1. Liquid-Phase Peptide Synthesis
    • 10.2.2. Solid-Phase Peptide Synthesis
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Therapeutics
    • 10.3.2. Diagnostics
    • 10.3.3. Research & Development
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Pharmaceutical & Biotechnology Companies
    • 10.4.2. CROs & CDMOs
    • 10.4.3. Academic & Research Institutes
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. Merck KGaA
    • 11.2.3. GenScript
    • 11.2.4. Agilent Technologies Inc.
    • 11.2.5. Bachem AG
    • 11.2.6. Waters Corporation
    • 11.2.7. Danaher
    • 11.2.8. PolyPeptide Group
    • 11.2.9. Bio-Synthesis Inc.
    • 11.2.10. CordenPharma

List of Tables

  • Table 1: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 2: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 3: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 4: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 5: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 6: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 7: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 8: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Region, 2021-2034
  • Table 9: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 10: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 11: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 12: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 13: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 14: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 15: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 16: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Country, 2021-2034
  • Table 17: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 18: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 19: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 20: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 21: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 22: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 23: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 24: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Country/Sub-Region, 2021-2034
  • Table 25: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 26: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 27: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 28: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 29: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 30: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 31: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 32: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Country/Sub-Region, 2021-2034
  • Table 33: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 34: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 35: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 36: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 37: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 38: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 39: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 40: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Country/Sub-Region, 2021-2034
  • Table 41: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 42: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 43: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 44: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 45: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 46: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 47: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 48: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Country/Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global Peptide Synthesis Market Revenue Breakdown (USD Million, %) By Region, 2025 & 2034
  • Figure 2: Global Peptide Synthesis Market Value Share (%), By Offering, 2025 & 2034
  • Figure 3: Global Peptide Synthesis Market Value Share (%), By Method, 2025 & 2034
  • Figure 4: Global Peptide Synthesis Market Value Share (%), By Application, 2025 & 2034
  • Figure 5: Global Peptide Synthesis Market Value Share (%), By End User, 2025 & 2034
  • Figure 6: Global Peptide Synthesis Market Value (USD Million), By Region, 2025 & 2034
  • Figure 7: North America Peptide Synthesis Market Value (USD Million), By Offering, 2025 & 2034
  • Figure 8: North America Peptide Synthesis Market Value Share (%), By Offering, 2025
  • Figure 9: North America Peptide Synthesis Market Value (USD Million), By Method, 2025 & 2034
  • Figure 10: North America Peptide Synthesis Market Value Share (%), By Method, 2025
  • Figure 11: North America Peptide Synthesis Market Value (USD Million), By Application, 2025 & 2034
  • Figure 12: North America Peptide Synthesis Market Value Share (%), By Application, 2025
  • Figure 13: North America Peptide Synthesis Market Value (USD Million), By End User, 2025 & 2034
  • Figure 14: North America Peptide Synthesis Market Value Share (%), By End User, 2025
  • Figure 15: North America Peptide Synthesis Market Value (USD Million), By Country, 2025 & 2034
  • Figure 16: North America Peptide Synthesis Market Value Share (%), By Country, 2025
  • Figure 17: Europe Peptide Synthesis Market Value (USD Million), By Offering, 2025 & 2034
  • Figure 18: Europe Peptide Synthesis Market Value Share (%), By Offering, 2025
  • Figure 19: Europe Peptide Synthesis Market Value (USD Million), By Method, 2025 & 2034
  • Figure 20: Europe Peptide Synthesis Market Value Share (%), By Method, 2025
  • Figure 21: Europe Peptide Synthesis Market Value (USD Million), By Application, 2025 & 2034
  • Figure 22: Europe Peptide Synthesis Market Value Share (%), By Application, 2025
  • Figure 23: Europe Peptide Synthesis Market Value (USD Million), By End User, 2025 & 2034
  • Figure 24: Europe Peptide Synthesis Market Value Share (%), By End User, 2025
  • Figure 25: Europe Peptide Synthesis Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Peptide Synthesis Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Peptide Synthesis Market Value (USD Million), By Offering, 2025 & 2034
  • Figure 28: Asia Pacific Peptide Synthesis Market Value Share (%), By Offering, 2025
  • Figure 29: Asia Pacific Peptide Synthesis Market Value (USD Million), By Method, 2025 & 2034
  • Figure 30: Asia Pacific Peptide Synthesis Market Value Share (%), By Method, 2025
  • Figure 31: Asia Pacific Peptide Synthesis Market Value (USD Million), By Application, 2025 & 2034
  • Figure 32: Asia Pacific Peptide Synthesis Market Value Share (%), By Application, 2025
  • Figure 33: Asia Pacific Peptide Synthesis Market Value (USD Million), By End User, 2025 & 2034
  • Figure 34: Asia Pacific Peptide Synthesis Market Value Share (%), By End User, 2025
  • Figure 35: Asia Pacific Peptide Synthesis Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Peptide Synthesis Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Peptide Synthesis Market Value (USD Million), By Offering, 2025 & 2034
  • Figure 38: Latin America Peptide Synthesis Market Value Share (%), By Offering, 2025
  • Figure 39: Latin America Peptide Synthesis Market Value (USD Million), By Method, 2025 & 2034
  • Figure 40: Latin America Peptide Synthesis Market Value Share (%), By Method, 2025
  • Figure 41: Latin America Peptide Synthesis Market Value (USD Million), By Application, 2025 & 2034
  • Figure 42: Latin America Peptide Synthesis Market Value Share (%), By Application, 2025
  • Figure 43: Latin America Peptide Synthesis Market Value (USD Million), By End User, 2025 & 2034
  • Figure 44: Latin America Peptide Synthesis Market Value Share (%), By End User, 2025
  • Figure 45: Latin America Peptide Synthesis Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Peptide Synthesis Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Peptide Synthesis Market Value (USD Million), By Offering, 2025 & 2034
  • Figure 48: Middle East & Africa Peptide Synthesis Market Value Share (%), By Offering, 2025
  • Figure 49: Middle East & Africa Peptide Synthesis Market Value (USD Million), By Method, 2025 & 2034
  • Figure 50: Middle East & Africa Peptide Synthesis Market Value Share (%), By Method, 2025
  • Figure 51: Middle East & Africa Peptide Synthesis Market Value (USD Million), By Application, 2025 & 2034
  • Figure 52: Middle East & Africa Peptide Synthesis Market Value Share (%), By Application, 2025
  • Figure 53: Middle East & Africa Peptide Synthesis Market Value (USD Million), By End User, 2025 & 2034
  • Figure 54: Middle East & Africa Peptide Synthesis Market Value Share (%), By End User, 2025
  • Figure 55: Middle East & Africa Peptide Synthesis Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Peptide Synthesis Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Peptide Synthesis Market Share (%), By Company, 2025